Joseph Zakrzewski, Director at Insulet, holds 529.08K shares in AN2 Therapeutics, Inc. (Ticker: ANTX), holds 376.49K shares in Cyteir Therapeutics (Ticker: CYT), holds 60.70K shares in Sangamo Biosciences (Ticker: SGMO). Most recently, Joseph Zakrzewski Bought ― shares of AN2 Therapeutics, Inc. on Nov 20, 2024 for an estimated value of 24.85K.
Joseph Zakrzewski latest transaction was an Informative Buy of $24.85K.
What was Joseph Zakrzewski's most profitable transaction?
Joseph Zakrzewski’s most profitable transaction was an Informative Buy of XLRN stock on June 17, 2019. The return on the trade was 155.10%.
What is Joseph Zakrzewski's role in Insulet?
Joseph Zakrzewski's role in Insulet is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.